Alerts will be sent to your verified email
Verify EmailLINCOLN
|
Lincoln Pharma
|
Kwality Pharma
|
Anuh Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Domestic Sales Growth - YoY
|
8.98 % | n/a | n/a |
|
R&D as a % of Total Sales
|
1.88 % | n/a | 0.0 |
|
Financials
|
|||
|
5 yr Average ROE
|
15.1 % | 25.27 % | 15.87 % |
|
5yr average Equity Multiplier
|
1.26 | 1.96 | 1.62 |
|
5yr Average Asset Turnover Ratio
|
0.82 | 1.05 | 1.35 |
|
5yr Avg Net Profit Margin
|
14.59 % | 11.66 % | 7.23 % |
|
Price to Book
|
1.57 | 3.56 | 2.76 |
|
P/E
|
12.21 | 21.64 | 19.49 |
|
5yr Avg Cash Conversion Cycle
|
-6.41 Days | 55.02 Days | 42.81 Days |
|
Inventory Days
|
43.91 Days | 67.04 Days | 50.87 Days |
|
Days Receivable
|
91.75 Days | 132.46 Days | 111.12 Days |
|
Days Payable
|
128.38 Days | 126.93 Days | 117.6 Days |
|
5yr Average Interest Coverage Ratio
|
63.13 | 16.13 | 48.66 |
|
5yr Avg ROCE
|
19.81 % | 34.73 % | 21.17 % |
|
5yr Avg Operating Profit Margin
|
18.35 % | 23.23 % | 10.21 % |
|
5 yr average Debt to Equity
|
0.0 | 0.46 | 0.02 |
|
5yr CAGR Net Profit
|
5.76 % | 21.34 % | 10.73 % |
|
5yr Average Return on Assets
|
11.92 % | 12.96 % | 9.84 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.78 % | 54.83 % | 71.82 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
5.7 % | 0.38 % | 1.23 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Lincoln Pharma
|
Kwality Pharma
|
Anuh Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|